Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract …
WEBPharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing. News and analysis on clinical trial services and contract research and development. NuraBio closes $140m fundraising to develop neuroprotective drugs. The series A financing will enable Nura Bio to advance its lead drug candidate into the next ...
Report: expect the future of US pharma market to be exciting
WEBAug 4, 2021 · Report: expect the future of US pharma market to be ‘exciting’. An industry study from the producer of CPhI North America shows the pandemic and other factors are contributing to a very dynamic pharmaceutical market. The COVID-19 pandemic has certainly had a tremendous impact on the pharmaceutical business.
Premier Research: holistic approach benefits development
WEBOct 6, 2020 · Holistic design starts off with designing a target product profile that considers the end goal early in the development planning. Also, part of a successful holistic approach, Sharif suggested, is asking thoughtful, appropriate questions at the outset, making sure to consider outcome-focused impactful issues at every stage of development.
Pharma SAAS solutions must balance safety, efficiency: IQVIA
WEBJul 9, 2021 · News and analysis on clinical trial services and contract research and development. Pharma SAAS solutions must balance safety, efficiency: IQVIA. A leader from IQVIA suggests what to look for when seeking ways to automate drug safety processes, while maintaining security and customer satisfaction. The …
The rise of the integrated research organization: A conversation …
WEBSep 11, 2019 · Behind the term is NC-based Javara, which made its official debut in June 2018 . The company’s CEO Jennifer Byrne told us the name ‘integrated research organization,’ or IRO, emerged as the descriptor for the new clinical research model following discussions with Wake Forest Baptist Health.
Manufacturing impurity delays Phathom’s drug commercialization
WEBJan 16, 2023 · In its most recent update, Phathom outlined that the FDA would no longer take any action on the new drug application (NDA) as a treatment for EE, on or prior to the target action date of January 11, 2023. The company did add that an acceptable daily intake limit for N-nitroso-vonoprazan (NVP), the impurity in question, had been set at …
Andreas Raabe – carving out a niche for Adragos Pharma
WEBApr 11, 2024 · Andreas Raabe, the visionary CEO behind Adragos Pharma, shares his insights into the company's recent expansion and strategic objectives. With a background in biology, Raabe embarked on a mission to transform the CDMO landscape, aiming to carve out a niche for Adragos Pharma as a dynamic and …
Roquette and Qualicaps combine to expand global footprint
WEBDec 8, 2023 · Qualicaps is an ideal addition to Roquette thanks to its shared commitment to innovation, quality and excellence. Its global footprint, with manufacturing and R&D sites in Japan, Spain, Romania, Canada, the USA, and Brazil, will allow Roquette to expand its presence and be closer to its customers and markets. Pierre Courduroux, CEO …
Lonza expands manufacturing with bottling and labeling at US site
WEBAug 15, 2024 · Lonza boosts clinical services with new bottling capabilities. Lonza, a global leader in the pharmaceutical, biotech, and nutraceutical markets, has announced a significant expansion of its clinical manufacturing services at its small molecules site in Bend, Oregon. The upgrade includes the installation of advanced bottling and labeling ...
Outsourcing-Pharma RSS
WEBBreaking News on Outsourcing Pharma. Outsourcing-Pharma RSS. The German big pharma will submit a new drug application to the US FDA after success at phase 3 for nerandomilast. Boehringer Ingelheim score with phase 3 idiopathic pulmonary fibrosis win. One year after a rejection by the US Food and Drug …